| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Pilnik Richard D. is a Director at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 38,363 | $3.91 | $149,999.33 | +18.3% | -29.4% | -49.2% | |
| Dec 5, 2022 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 35,000 | $1.39 | $48,492.50 | +29.3% | +35.9% | +96.9% | |
| Aug 16, 2021 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 15,000 | $3.27 | $49,064.00 | +9.2% | +22.5% | -44.1% | |
| Dec 4, 2020 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 10,000 | $5.37 | $53,697.00 | +7.9% | - | - | |
| Aug 16, 2019 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 7,840 | $2.56 | $20,039.04 | +18.3% | - | - | |
| May 31, 2019 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 19,000 | $2.80 | $53,200.00 | +79.7% | - | - | |
| Dec 11, 2018 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 6,250 | $4.00 | $25,000.00 | +35.5% | - | - |